Ann Thomas Tate

Ann Thomas Tate

Auto-generated profile, based on publicly available information

Ann Thomas Tate

Vanderbilt University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2016 in PLOS Biology
Verified
Journal Article
Open access
PDF file
BTBrenda Y. Torres
Brenda Y. Torres
JOJose Henrique M. Oliveira
Jose Henrique M. Oliveira
ATAnn Thomas Tate
Ann Thomas Tate
PRPoonam Rath
Poonam Rath
KCKatherine Cumnock
Katherine Cumnock
DSDavid S. Schneider
David S. Schneider
Infected hosts differ in their responses to pathogens; some hosts are resilient and recover their original health, whereas others follow a divergent path and die. To quantitate these differences, we propose mapping the routes infected individuals take through “disease space.” We find that when plotting physiological parameters against each other, many pairs have hysteretic relationships that identify the current location of the host and predict the future route of the infection. These maps can readily be constructed from experimental longitudinal data, and we provide two methods to generate the maps from the cross-sectional data that is commonly gathered in field trials. We hypothesize that resilient hosts tend to take small loops through disease space, whereas nonresilient individuals take large loops. We support this hypothesis with experimental data in mice infected with Plasmodium chabaudi, finding that dying mice trace a large arc in red blood cells (RBCs) by reticulocyte space as compared to surviving mice. We find that human malaria patients who are heterozygous for sickle cell hemoglobin occupy a small area of RBCs by reticulocyte space, suggesting this approach can be used to distinguish resilience in human populations. This technique should be broadly useful in describing the in-host dynamics of infections in both model hosts and patients at both population and individual levels. When we get sick, we long for recovery; thus, a major goal of medicine is to promote resilience—the ability of a host to return to its original health following an infection. While in the laboratory we can study the response to infection with precise knowledge of inoculation time and dose, sick patients in the clinic do not have this information. This creates a problem because we can’t easily differentiate between patients who are early in the stages of infection that will develop severe disease from more disease-tolerant patients who present later in the infection. The distinction between these two types of patients is important, as the less disease-tolerant patient would require a more aggressive treatment regime. To determine where patients lie along the infection timeline, we charted “disease maps” that trace a patient’s route through “disease space.” We select symptoms that produce looping graphs as patients grow sick and recover. Using a mouse–malaria model, we demonstrate that less resilient individuals take wider loops through this space, representing a longer infection time with more severe symptoms. We find this looping behavior also applies to humans and suggest that people carrying the sickle cell trait are more resilient to malaria infections.

18 April 2016 in PLOS Biology
Verified
Journal Article
Open access
PDF file
ALAlexander Louie
Alexander Louie
KSKyung Han Song
Kyung Han Song
AHAlejandra Hotson
Alejandra Hotson
ATAnn Thomas Tate
Ann Thomas Tate
DSDavid S. Schneider
David S. Schneider
The study of infectious disease has been aided by model organisms, which have helped to elucidate molecular mechanisms and contributed to the development of new treatments; however, the lack of a conceptual framework for unifying findings across models, combined with host variability, has impeded progress and translation. Here, we fill this gap with a simple graphical and mathematical framework to study disease tolerance, the dose response curve relating health to microbe load; this approach helped uncover parameters that were previously overlooked. Using a model experimental system in which we challenged Drosophila melanogaster with the pathogen Listeria monocytogenes, we tested this framework, finding that microbe growth, the immune response, and disease tolerance were all well represented by sigmoid models. As we altered the system by varying host or pathogen genetics, disease tolerance varied, as we would expect if it was indeed governed by parameters controlling the sensitivity of the system (the number of bacteria required to trigger a response) and maximal effect size according to a logistic equation. Though either the pathogen or host immune response or both together could theoretically be the proximal cause of pathology that killed the flies, we found that the pathogen, but not the immune response, drove damage in this model. With this new understanding of the circuitry controlling disease tolerance, we can now propose better ways of choosing, combining, and developing treatments. It is an intuitive assumption that the severity of symptoms suffered during an infection must be linked to pathogen loads. However, the dose–response relationship explaining how health varies with respect to pathogen load is non-linear and can be described as a “disease tolerance curve;” this relationship can vary in response to the genetic properties of the host or pathogen as well as environmental conditions. We studied what changes in the shape of this curve can teach us about the underlying circuitry of the immune response. Using a model system in which we infected fruit flies with the bacterial pathogen Listeria monocytogenes, we observed an S-shaped disease tolerance curve. This type of curve can be described by three or four parameters in a standard manner, which allowed us to develop a simple mathematical model to explain how the curve is expected to change shape as the immune response changes. After observing the variation in curve shape due to host and pathogen genetic variation, we conclude that the damage caused by Listeria infection does not result from an over-exuberant immune response but rather is caused more directly by the pathogen.

9 March 2017 in Molecular Ecology
Verified
Journal Article
Closed access
PDF file
ATAnn T. Tate
Ann T. Tate
PAPeter Andolfatto
Peter Andolfatto
JDJeffery P. Demuth
Jeffery P. Demuth
AGAndrea L. Graham
Andrea L. Graham


8 December 2011 in Oikos
Verified
Journal Article
Closed access
PDF file
ATAnn T. Tate
Ann T. Tate
VRVolker H. W. Rudolf
Volker H. W. Rudolf

1 November 2018 in Trends in Immunology
Verified
Journal Article
Closed access
DSDana K Shaw
Dana K Shaw
ATAnn T. Tate
Ann T. Tate
DSDavid S. Schneider
David S. Schneider
ELElena A. Levashina
Elena A. Levashina
JKJonathan C. Kagan
Jonathan C. Kagan
JPJoao Pedra
Joao Pedra